Notably, we demonstrated for the first time that TGF‐β was highly expressed in both GCB and non‐GCB subtypes of DLBCL, and that it functioned as a dominant immunosuppressive axis specifically in the GCB context, consistented with our experimental findings. Here, TGFB1 is linked to diffuse large B-cell lymphoma.